Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) [1] is a sub-office of the ASA(ALT).. The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense is the Joint Service’s lead for development, acquisition, fielding and life-cycle support of chemical, biological, radiological and nuclear defense equipment ...
The Medical CBRN (Chemical, Biological, Radiological and Nuclear) Defense Consortium, a DOD initiative within its Joint Program Executive Office for Chemical and Biological Defense has awarded the company US$20 million to develop an auto-injector to administer diazepam.
Invesco Aerospace & Defense ETF is an exchange-traded fund with over 90% of its holdings in stocks that comprise the index. Its top five holdings, in order, are RTX Corp., Lockheed Martin, Boeing ...
Pages in category "Chemical, biological, radiological and nuclear defense" The following 11 pages are in this category, out of 11 total. This list may not reflect recent changes .
Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida.The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. [3]
The 20th CBRNE Command is the United States Army headquarters for defense against Chemical, Biological, Radiological, Nuclear, and high-yield Explosives (CBRNE), headquartered on the site of the defunct Edgewood Arsenal chemical weapons production facility at Aberdeen Proving Ground in northern Maryland.
So far this year, this Zacks Rank #3 (Hold) stock has lost 7.4% compared with a 13.3% fall of the industry and an 18.3% decline of the S&P 500. This renowned medical-devices provider has a market ...